Comments on Petherbridge, et al., Unenforceability Discussant: Brian Love 7 th Annual Conference on Empirical Legal Studies November 9, 2012.

Slides:



Advertisements
Similar presentations
Preparing for Changes in the Treatment of US Patents Chinh H. Pham Greenberg Traurig Thomas A. Turano K&L Gates MassMedic March 6, 2008.
Advertisements

Prosecution Group Luncheon June, 2011 Patents. Clear and Convincing Survives Microsoft Corp. v. i4i Ltd. Pship (US 2011) §282 requires proof of invalidity.
Dan Turton Victoria University of Wellington
By David W. Hill AIPLA Immediate Past President Partner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Overview of the America Invents Act.
Slide 0 Refusals To License IP Jonathan I. Gleklen Partner Arnold & Porter The opinions expressed are those of the author and do not necessarily represent.
Patent Animation Litigation Timeline 4.
Inequitable Conduct-Therasense, Inc. v. Beckton, Dickinson & Co. J. Gibson Lanier, Ph.D. Patent Attorney Ballard Spahr LLP
1 Rule 132 Declarations and Unexpected Results Richard E. Schafer Administrative Patent Judge Board of Patent Appeals and Interferences.
Patent Portfolio Management By: Michael A. Leonard II.
© 2011 Hultquist IP. All rights reserved.
1 What’s different about patents across industries? —and so what? Wesley M. Cohen Duke University Conference on Patents and Diversity in Innovation University.
1 Best Practices in Legal Holds Effectively Managing the e-Discovery Process and Associated Costs.
Professor Vicki Waye Law School Division of Business UniSA
The Changing Law of Inequitable Conduct Rachel Zimmerman of Merchant & Gould Rebecca Thorson of Robins, Kaplan, Miller & Ciresi presented by.
AMERICA INVENTS ACT A Look Into The Future
Antitrust Counterclaims: The Basics Daniel M. Wall San Francisco
Post Therasense Cases and Practical Tips Studebaker Brackett PC January, 2013 AIPLA 1.
* Statements of fact and opinions expressed are those of the speaker individually and are not the opinion or position of Research In Motion Limited or.
Planning, Outlining, Drafting e.g. Formally Starting the Process.
Prosecution Delay Laches and Inequitable Conduct Prof Merges 11/23/2010.
CENTER FOR ADVANCED STUDY & RESEARCH ON INTELLECTUAL PROPERTY 2002 HIGH TECHNOLOGY PROTECTION SUMMIT Ethical Issues In Patent Law Inequitable Conduct –
Applications for Intellectual Property International IP Protection IP Enforcement Protecting Software JEFFREY L. SNOW, PARTNER NATIONAL SBIR/STTR CONFERENCE.
Prosecution Delay Laches and Inequitable Conduct Prof Merges 11/22/2011.
Written Patent Discovery  Decline of notice pleading and its impact on patent litigation  Rule 26, FRCP and written patent discovery  Local Patent Rules.
Secondary Use Patents: An international and Canadian perspective E. Richard Gold James McGill Professor, McGill Faculty of Law Secondary Use Pharmaceutical.
Patenting Wireless Technology: Infringement and Invalidity Dr. Tal Lavian UC Berkeley Engineering,
FRCP & Ethics Money & Ethics Technology & Ethics USPTO & Ethics Advertising Ethics
January 28, AIPLA Conference January 2004 New Defensive Tools For Japanese Patent Litigation Yoshikazu Iwase Anderson.
ENFORCEMENT OF IP RIGHTS – INFRINGEMENT SEIZURE IN FRANCE Didier Intès French & European Patent attorney AIPPI – November 7, 2013.
Ethical Issues for Patent Prosecution Attorneys and Patent Litigators Related to the Duty of Candor and Inequitable Conduct April 22, 2008 Presentation.
Our Divided Patent System John R. Allison University of Texas McCombs School of Business Mark A. Lemley Stanford Law School David L. Schwartz Northwestern.
1 Therasense v. Becton Dickinson and Bayer John M. Whealan Associate Dean for IP Law George Washington Law School.
Prosecution Lunch Patents January Reminder: USPTO Fee Changes- Jan. 1, 2014 Issue Fee Decrease- delay paying if you can –Issue Fee: from $1,780.
Defenses & Counterclaims II Class Notes: March 25, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
AIPLA Practical Patent Prosecution Training for New Lawyers Electrical, Computer & Software Claim Drafting Rick A. Toering | |
1 Inequitable Conduct in the Prosecution of Pharmaceutical and Biotechnology Patents Stephen D. Harper, Ph.D RatnerPrestia April 1, 2011.
Intellectual property research institute of australia IP Enforcement in Australia What’s Actually Happening in the Courts? Presentation by: Kim Weatherall.
1 1 AIPLA Firm Logo American Intellectual Property Law Association The Presumption of Patent Validity in the U.S. Tom Engellenner AIPLA Presentation to.
Challenges Associated With, And Strategies For, U.S. Patent Litigation Russell E. Levine, P.C. Kirkland & Ellis LLP LES Asia.
Patent Prosecution May PCT- RCE Zombie 371 National Stage PCT Applications –Not Allowed to file an RCE until signed inventor oath/declaration is.
© 2013 Kilpatrick Townsend December 4, 2013 Best Practices – Ethics Issues in the Patent Area Presented by Thomas Franklin, Partner Kristopher Reed, Partner.
© COPYRIGHT DICKSTEIN SHAPIRO LLP. ALL RIGHTS RESERVED. Post Grant Proceedings Before the USPTO and Litigation Strategies Under the AIA Panelists:David.
Are All Patent Examiners Equal?: The Impact of Examiner Characteristics on Patent Statistics & Litigation Outcomes Iain Cockburn, Boston University & NBER.
1 1 AIPLA Firm Logo American Intellectual Property Law Association Inequitable Conduct: Update Mark Guetlich AIPLA Mid-Winter JP Practice Committee Orlando.
Workshop on research agenda motivation: –complex-product technologies, abstraction, economic disruption –need for interdisciplinary approach (EPIP) –limitations:
LAW OF COMPUTER TECHNOLOGY FALL 2015 © 2015 MICHAEL I. SHAMOS Patents Michael I. Shamos, Ph.D., J.D. Institute for Software Research School of Computer.
The Impact of Student Self-e ffi cacy on Scientific Inquiry Skills: An Exploratory Investigation in River City, a Multi-user Virtual Environment Presenter:
Derivation Proceedings Gene Quinn Patent Attorney IPWatchdog.com March 27 th, 2012.
Prosecution Group Luncheon Patent October PTO News Backlog of applications continues to decrease –623,000 now, decreasing about 5,000/ month –Expected.
Law in the Global Marketplace: Intellectual Property and Related Issues Hosted by: Update on U.S. Patent Legislation.
Update on IP High Court -Trend of Determination on Inventive Step in IP High Court in comparison with the JPO- JPAA International Activities Center Toshifumi.
The Practice of Statistics Third Edition Chapter 11: Testing a Claim Copyright © 2008 by W. H. Freeman & Company Daniel S. Yates.
Could a Patent Term Reduction Solve the Software Patent Problem? Brian Love.
Some Things We Know About Software Patents From Empirical Research John Allison—UT Austin Software patent = claims cover data processing (manipulation.
1 TOPIC III - PATENT INVALIDATION PROCEDURES EU-CHINA WORKSHOP ON THE CHINESE PATENT LAW HARBIN, SEPTEMBER 2008 Dr. Gillian Davies.
Section 285 Litigation Ethics Conflicts of Interest Prosecution Bars Grab bag
1/30 PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
Chapter 3 The U.S. Legal System Chapter 3: The U.S. Legal System
The position in the UK Dr Ali Al-Alfatlawi.
Amy Semet, Princeton University
AIPLA Practical Patent Prosecution Training for New Lawyers
War Criminals & Crimes Against Humanity
Patent Practice in View Of PTAB AIA Proceedings
David Hricik Hope Shimabuku Carlo Cotrone Chris Kennerly
© 2006 Brett J. Trout Patent Reform Act of 2005 © 2006 Brett J. Trout
Danial Asmat & Sharon Tennyson “Tort Liability and Settlement Failure: Evidence on Litigated Auto Insurance Claims” Comment by Dan Klerman USC Law School.
Patents VI Infringement & the Doctrine of Equivalents
Alex Stein (coauthored with Gideon Parchomovsky)
Information Disclosure Statements
Presentation transcript:

Comments on Petherbridge, et al., Unenforceability Discussant: Brian Love 7 th Annual Conference on Empirical Legal Studies November 9, 2012

Some Specific Methodological Points  Invalidity database: –Why exclude patents invalidated under 102? –Why exclude patents invalidated for claim indefiniteness from database of invalid patents?  Why not include district court inequitable conduct findings that were never appealed or were summarily affirmed? –Are virtually all findings appealed? Maybe, due to harsh outcome? –If so, does a doctrine that knocks out only ~ 3 patents per year have much of an impact at all?

Alternative Explanation: Hapless vs. Deceptive  Unenforceable patents look as predicted, but should they? –“intent to deceive” > gross negligence  Possible IC is ensnaring those who’re merely careless or not patent-savvy, but subjectively intentless ? –Are these low-hanging fruit hanging a little too low for comfort? –Might patentees who are scheming against the PTO to get a valuable patent at all cost also be savvy enough to cover their tracks? –For example, by disclosing extra (immaterial) references, or reducing the number of interactions with the PTO to reduce risk of that killer prior art being discovered, etc.

Alternative Explanation: Hapless v. Deceptive  Similarities between unlitigated patents and unenforceable patents (p. 19). –Similar propensity to disclose references –Both relatively unlikely to be from industries most affected by patent system: pharmaceuticals and computing  Both prosecuted by relatively non-savvy/disinterested patentees? –Rather than police mechanism for those who scheme to get a patent they foresee using... is IC a trap for those who ultimately litigate patents they didn’t expect ex ante to litigate?  Evidence that might tend to support or refute this: –Are unenforceable patents disproportionately prosecuted by small entities? By individuals? By entities with few existing patents? –Characteristics broken down by whether evidence of intent was direct or indirect? (more on this in 1 second)

Future Research Dramatic shift in law over the study period ( ):  Are we getting better or worse at singling out bad actors? –Compare characteristics pre/post Kingsdown ; pre/post Therasense  Possible results driven by older “sliding scale”-era cases? –Pre- Kingsdown, hapless conduct re very material info likely IC  True that inequitable conduct floods the PTO with immaterial references? –Has the number of disclosed refs changed pre/post Kingsdown ; pre/post Therasense

Future Research  Are we punishing the right entity? –How often is the patentee at the time of litigation the same one who prosecuted the patent? –How often does the misconduct appear to be on the part of the patentee acting alone; i.e., without the knowledge of her attorney/agent? (or vice versa) –How often are ethical proceedings or malpractice claims brought against the attorneys/agents involved?  Comparison to non-infringed patents? –Lengthy prosecution tends to increase claim complexity, decrease claim scope? –How many patents might have been found not infringed absent IC ruling?